| Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort A Ito, T Ishida, H Tokumasu, Y Washio, A Yamazaki, Y Ito, H Tachibana BMC pulmonary medicine 17, 1-10, 2017 | 115 | 2017 |
| Risks of mortality and airflow limitation in Japanese individuals with preserved ratio impaired spirometry Y Washio, S Sakata, S Fukuyama, T Honda, K Kan-o, M Shibata, J Hata, ... American Journal of Respiratory and Critical Care Medicine 206 (5), 563-572, 2022 | 39 | 2022 |
| Legionella pneumonia due to non-Legionella pneumophila serogroup 1: usefulness of the six-point scoring system A Ito, T Ishida, Y Washio, A Yamazaki, H Tachibana BMC pulmonary medicine 17, 1-9, 2017 | 24 | 2017 |
| A phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small-cell lung cancer (KTORG1402) T Yokoyama, H Yoshioka, D Fujimoto, Y Demura, K Hirano, T Kawai, ... Lung Cancer 135, 175-180, 2019 | 22 | 2019 |
| Risk factors for drug-resistant pathogens in immunocompetent patients with pneumonia: evaluation of PES pathogens T Ishida, A Ito, Y Washio, A Yamazaki, M Noyama, F Tokioka, M Arita Journal of Infection and Chemotherapy 23 (1), 23-28, 2017 | 21 | 2017 |
| Impact of procalcitonin-guided therapy for hospitalized community-acquired pneumonia on reducing antibiotic consumption and costs in Japan A Ito, T Ishida, H Tokumasu, Y Washio, A Yamazaki, Y Ito, H Tachibana Journal of Infection and Chemotherapy 23 (3), 142-147, 2017 | 20 | 2017 |
| Evaluation of pneumonia severity scoring systems in nursing and healthcare-associated pneumonia for predicting prognosis: a prospective, cohort study A Ito, T Ishida, H Tokumasu, A Yamazaki, Y Washio Journal of infection and chemotherapy 26 (4), 372-378, 2020 | 17 | 2020 |
| Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis A Ito, T Ishida, H Tachibana, H Tokumasu, A Yamazaki, Y Washio Scientific Reports 9 (1), 18406, 2019 | 13 | 2019 |
| A model for predicting bacteremia in patients with community-acquired pneumococcal pneumonia: a retrospective observational study Y Washio, A Ito, S Kumagai, T Ishida, A Yamazaki BMC Pulmonary Medicine 18, 1-8, 2018 | 13 | 2018 |
| Differences in the spectrum of respiratory viruses and detection of human rhinovirus C in exacerbations of adult asthma and chronic obstructive pulmonary disease K Kan-o, Y Washio, T Fujimoto, N Shiroyama, T Nakano, K Wakamatsu, ... Respiratory Investigation 60 (1), 129-136, 2022 | 12 | 2022 |
| Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia A Ito, T Ishida, H Tachibana, M Arita, A Yamazaki, Y Washio Clinical Chemistry and Laboratory Medicine (CCLM) 57 (10), 1632-1637, 2019 | 11 | 2019 |
| Polymicrobial etiology as a prognostic factor for empyema in addition to the renal, age, purulence, infection source, and dietary factors score A Yamazaki, A Ito, T Ishida, Y Washio Respiratory Investigation 57 (6), 574-581, 2019 | 10 | 2019 |
| Time trend of the sensitivity of the pneumococcal urinary antigen test for diagnosing pneumococcal community-acquired pneumonia: an analysis of 15-year, prospective cohort data A Ito, T Ishida, H Tachibana, Y Nakanishi, A Yamazaki, Y Washio Infectious Diseases and Therapy 10, 2309-2322, 2021 | 7 | 2021 |
| Increased risk of Legionella pneumonia as community-acquired pneumonia after heavy rainfall in 2018 in west Japan M Mitsui, A Ito, T Ishida, H Tachibana, Y Nakanishi, A Yamazaki, ... Journal of Infection and Chemotherapy 27 (10), 1429-1435, 2021 | 6 | 2021 |
| Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis … A Ito, T Ishida, H Tachibana, Y Nakanishi, F Tokioka, A Yamazaki, ... Journal of Infection and Chemotherapy 27 (10), 1447-1453, 2021 | 3 | 2021 |
| Is antipseudomonal antibiotic treatment needed for all nursing and healthcare-associated pneumonia patients at risk for antimicrobial resistance? A Ito, T Ishida, H Tachibana, Y Nakanishi, A Yamazaki, Y Washio Journal of Global Antimicrobial Resistance 22, 441-447, 2020 | 2 | 2020 |
| Predictive performance of quick sepsis-related organ failure assessment for mortality and intensive care unit admission among patients with community-acquired pneumonia F Tokioka, H Okamoto, Y Washio, A Yamazaki, A Ito, T Ishida B61. BACTERIAL RESPIRATORY INFECTIONS, A3952-A3952, 2017 | 2 | 2017 |
| Identification rate of Legionella species in non-purulent sputum culture is comparable to that in purulent sputum culture in Legionella pneumonia A Ito, T Ishida, H Tachibana, Y Nakanishi, M Kawataki, A Yamazaki, ... Journal of Clinical Microbiology 62 (4), e01665-23, 2024 | 1 | 2024 |
| Novel FEV1/FVC-based Diagnosis and Severity Classification of Chronic Obstructive Pulmonary Disease: How about FEV1 % Predicted Basing? H Ogata, Y Washio, M Yoshida American Journal of Respiratory and Critical Care Medicine 209 (3), 340-341, 2024 | 1 | 2024 |
| Novel FEV1/FVC-based Diagnosis and Severity Classification of Chronic Obstructive Pulmonary Disease: How About FEV1 Percent Predicted Basing? H Ogata, Y Washio, M Yoshida American Journal of Respiratory and Critical Care Medicine, 2023 | 1 | 2023 |
